[1] Pereg D, Koren G, Lishner M.Cancer in pregnancy: gaps, challenges and solutions[J]. Cancer Treat Rev, 2008, 34(4): 302-312. [2] Figueiró-Filho EA, Horgan RP, Muhanna N, et al.Obstetrical outcomes of head and neck (nonthyroid) cancers: a 27-year retrospective series and literature review[J]. AJP Rep, 2019, 9(1): e15-e22. [3] 段娟, 陈龙, 范悦玲, 等. 妊娠期恶性肿瘤孕产妇和新生儿结局的前瞻性队列研究[J]. 中国循证儿科杂志, 2017, 12(5): 328-332. Duan J, Chen L, Fan YL, et al.Maternal and pediatric outcome after maternal cancer diagnosed during pregnancy: a cohort study[J]. Chinese Journal of Evidence Based Pediatrics, 2017, 12(5): 328-332. [4] Boere I, Lok C, Poortmans P, et al.Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities[J]. Best Pract Res Clin Obstet Gynaecol, 2022, 82: 46-59. [5] Causa Andrieu PI, Wahab SA, Nougaret S, et al.Ovarian cancer during pregnancy[J]. Abdom Radiol (NY), 2023, 48(5): 1694-1708. [6] Chow LQM.Head and neck cancer[J]. N Engl J Med, 2020, 382(1): 60-72. [7] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [8] Liao CI, Francoeur AA, Kapp DS, et al.Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017[J]. JAMA Netw Open, 2022, 5(3): e222530. [9] Morrison AE, Lang PG.Case of rapidly enlarging dermatofibrosarcoma protuberans during pregnancy followed by metastasis in the absence of local recurrence[J]. Dermatol Surg, 2006, 32(1): 125-127. [10] Murgia F, Marinaccio M, Cormio G, et al.Pregnancy related cancer in Apulia. A population based linkage study[J]. Eur J Obstet Gynecol Reprod Biol X, 2019, 3: 100025. [11] Zanoni DK, Patel SG, Shah JP.Changes in the 8th edition of the American Joint Committee on Cancer (AJCC) staging of head and neck cancer: rationale and implications[J]. Curr Oncol Rep, 2019, 21(6): 52-74. [12] Hanahan D.Hallmarks of cancer: new dimensions[J]. Cancer Discov, 2022, 12(1): 31-46. [13] Lambert AW, Weinberg RA.Linking EMT programmes to normal and neoplastic epithelial stem cells[J]. Nat Rev Cancer, 2021, 21(5): 325-338. [14] Chow VL, Chan JY, Ng RW, et al.Management of head and neck tumours during pregnancy: case report and literature review[J]. Asian J Surg, 2008, 31(4): 199-203. [15] Eliassen AM, Hauff SJ, Tang AL, et al.Head and neck squamous cell carcinoma in pregnant women[J]. Head Neck, 2013, 35(3): 335-342. [16] Unsworth JD, Baldwin A, Byrd L.Systemic lupus erythematosus, pregnancy and carcinoma of the tongue[J]. BMJ Case Rep, 2013: bcr2013008864. [17] Yokoshima K, Nakamizo M, Sakanushi A, et al.Surgical management of tongue cancer during pregnancy[J]. Auris Nasus Larynx, 2012, 39(4): 428-430. [18] Mhallem Gziri M, Han SN, Van Calsteren K, et al.Tongue cancers during pregnancy: case reports and review of literature[J]. Head Neck, 2013, 35(4): E102-E108. [19] Cheung EJ, Wagner H Jr, Botti JJ, et al.Advanced oral tongue cancer in a 22-year-old pregnant woman[J]. Ann Otol Rhinol Laryngol, 2009, 118(1): 21-26. [20] Atabo A, Bradley PJ.Management principles of head and neck cancers during pregnancy: a review and case series[J]. Oral Oncol, 2008, 44(3): 236-241. [21] Dumper J, Kerr P.Recurrent squamous cell carcinoma of the tongue in pregnancy[J]. J Otolaryngol, 2005, 34(4): 242-243. [22] Koike T, Uehara S, Kobayashi H, et al.Squamous cell carcinoma of the tongue during pregnancy experiences in two-year treatments[J]. Oral Oncol Extra, 2005, 41(1):7-11. [23] Lloyd CJ, Paley MD, Penfold CN, et al.Microvascular free tissue transfer in the management of squamous cell carcinoma of the tongue during pregnancy[J]. Br J Oral Maxillofac Surg, 2003, 41(2): 109-111. [24] Prado KL, Nelson SJ, Nuyttens JJ, et al.Clinical implementation of the AAPM task group 36 recommendations on fetal dose from radiotherapy with photon beams: a head and neck irradiation case report[J]. J Appl Clin Med Phys, 2000, 1(1):1-7. [25] Lasaridis N, Tilaveridis I, Karakasis D.Management of a carcinoma of the tongue during pregnancy: report of case[J]. J Oral Maxillofac Surg, 1996, 54(2): 221-224. [26] Terada T, Uwa N, Sagawa K, et al.A case of tongue carcinoma resection and reconstruction with microsurgical free flap during pregnancy[J]. Nihon Jibiinkoka Gakkai Kaiho, 2015, 118(1): 46-52. [27] Shibuya H, Saiot M, Horiuchi JI, et al.Treatment of malignant head and neck tumors during pregnancy-a report of 3 cases[J]. Acta Oncol, 1987, 26(3): 237-238. [28] Tagliabue M, Elrefaey SH, Peccatori F, et al.Tongue cancer during pregnancy: surgery and more, a multidisciplinary challenge[J]. Crit Rev Oncol Hematol, 2016, 98: 1-11. [29] Kansu L, Aydin E.Hypopharyngeal cancer in a pregnant woman[J]. Am J Otolaryngol, 2012, 33(1): 174-177. [30] Liu Y, Liu Y, Wang Y, et al.Malignancies associated with pregnancy: an analysis of 21 clinical cases[J]. Ir J Med Sci, 2015, 184(1): 175-181. [31] Lin TI, Lin JC, Ho ES, et al.Nasopharyngeal carcinoma during pregnancy[J]. Taiwan J Obstet Gynecol, 2007, 46(4): 423-426. [32] Pytel J, Gerlinger I, Arany A.Twin pregnancy following in vitro fertilisation coinciding with laryngeal cancer[J]. ORL J Otorhinolaryngol Relat Spec, 1995, 57(4): 232-234. [33] Matschke RG, Gräber T, Panagiotopoulos A.A laryngeal cancer in pregnancy[J]. HNO, 1994, 42(8): 505-508. [34] Panagiotopoulos A, Matschke R, Faber P.Pregnancy and laryngeal cancer[J]. Geburtshilfe Frauenheilkd, 1993, 53(1): 64-65. [35] Ferlito A, Nicolai P.Laryngeal cancer in pregnancy[J]. Acta Otorhinolaryngol Belg, 1980, 34(6): 706-709. [36] Tota JE, Anderson WF, Coffey C, et al.Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012[J]. Oral Oncol, 2017, 67(2): 146-152. [37] Mallet Y, Avalos N, Le Ridant AM, et al.Head and neck cancer in young people: a series of 52 SCCs of the oral tongue in patients aged 35 years or less[J]. Acta Otolaryngol, 2009, 129(12): 1503-1508. [38] Batistella EÂ, Gondak R, Rivero ERC, et al.Comparison of tobacco and alcohol consumption in young and older patients with oral squamous cell carcinoma: a systematic review and meta-analysis[J]. Clin Oral Investig, 2022, 26(12): 6855-6869. [39] O'Regan EM, Toner ME, Smyth PC, et al. Distinct array comparative genomic hybridization profiles in oral squamous cell carcinoma occurring in young patients[J]. Head Neck, 2006, 28(4): 330-338. [40] Cheng YK, Zhang F, Tang LL, et al.Pregnancy associated nasopharyngeal carcinoma: a retrospective case-control analysis of maternal survival outcomes[J]. Radiother Oncol, 2015, 116(1): 125-130. [41] Zhang L, Liu H, Tang LQ, et al.Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysis[J]. Oncotarget, 2016, 7(16): 21913-21921. [42] Hoorn EJ, Monserez DA, Fenton RA, et al.Olfactory neuroblastoma with hyponatremia[J]. J Clin Oncol, 2015, 33(21): e88-e92. [43] Skorek A, Stankiewicz C, Preis K, et al.Malignant tumor of nasal cavity during pregnancy. Case report[J]. Otolaryngol Pol, 2012, 66(6): 428-431. [44] Senchak A, Freeman J, Ruhl D, et al.Low-grade esthesioneuroblastoma presenting as SIADH: a review of atypical manifestations[J]. Case Rep Otolaryngol, 2012: 582180. [45] Dascalu S, Chayen B, Kaplan B, et al.Olfactory neuroblastoma as acute postpartum depression[J]. J Am Board Fam Pract, 1998, 11(5): 414-416. [46] Kumar M, Stivaros N, Barrett AW, et al.Polymorphous low-grade adenocarcinoma-a rare and aggressive entity in adolescence[J]. Br J Oral Maxillofac Surg, 2004, 42(3): 195-199. [47] Prabhu RV, Dinkar A, Spadigam A, et al.Low-grade papillary adenocarcinoma of minor salivary glands in pregnancy[J]. Indian J Cancer, 2015, 52(4): 644-645. [48] Takita M, Taniguchi B, Iriki-in M, et al. Adenoidcystic carcinoma of the palate in pregnancy: report of a case[J]. Osaka Daigaku Shigaku Zasshi, 1989, 34(1): 255-263. [49] Arango JF, López JC, Arrazubi V, et al. An unusual neck tumor in a young pregnant woman: challenge diagnosis and response to treatment[J]. Oxf Med Case Reports, 2017(8): omx039. [50] Gherman RB, Bowen E, Eggleston MK, et al.Desmoid tumor of the larynx complicating pregnancy: a case report[J]. Am J Obstet Gynecol, 1999, 180(4): 1036-1037. [51] Mikaelian DO, Contrucci RB, Batsakis JG.Epithelial-myoepithelial carcinoma of the subglottic region: a case presentation and review of the literature[J]. Otolaryngol Head Neck Surg, 1986, 95(1): 104-106. [52] Werner JA, Hansmann ML, Lippert BM, et al.Laryngeal paraganglioma and pregnancy[J]. ORL J Otorhinolaryngol Relat Spec, 1992, 54(3): 163-167. [53] Feldman BA.Rhabdomyosarcoma of the head and neck[J]. Laryngoscope, 1982, 92(4): 424-440. [54] Tapisiz OL, Gungor T, Ustunyurt E, et al.An unusual case of lingual alveolar soft part sarcoma during pregnancy[J]. Taiwan J Obstet Gynecol, 2008, 47(2): 212-214. [55] Williams AO, Martinson FD, Alli AF.Rhabdomyosarcoma of the upper respiratory tract in Ibadan, Nigeria[J]. Br J Cancer, 1968, 22(1): 12-18. [56] Ortiz M, Giraldez LA, Riera-March A.Synovial sarcoma of the hypopharynx in pregnancy[J]. Bol Asoc Med P R, 2012, 104(3): 55-56. [57] Karapantzos I, Behrmann R, Kehl R, et al.Angiosarcoma of the nasal septum[J]. Laryngorhinootologie, 1998, 77(9): 513-516. [58] Jethanamest D, Morris LG, Sikora AG, et al.Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors[J]. Arch Otolaryngol Head Neck Surg, 2007, 133(3): 276-280. [59] Platek ME, Merzianu M, Mashtare TL, et al.Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database[J]. Radiat Oncol, 2011, 6: 41. [60] Fiore M, Coppola S, Cannell AJ, et al.Desmoid-type fibromatosis and pregnancy: a multi-institutional analysis of recurrence and obstetric risk[J]. Ann Surg, 2014, 259(5): 973-978. [61] Reitamo JJ, Scheinin TM, Häyry P.The desmoid syndrome. New aspects in the cause, pathogenesis and treatment of the desmoid tumor[J]. Am J Surg, 1986, 151(2): 230-237. [62] Vasco Ramirez M, Valencia GCM.Anesthesia for nonobstetric surgery in pregnancy[J]. Clin Obstet Gynecol, 2020, 63(2): 351-363. [63] Cardonick E, Iacobucci A.Use of chemotherapy during human pregnancy[J]. Lancet Oncol, 2004, 5(5): 283-291. [64] Brewer M, Kueck A, Runowicz CD.Chemotherapy in pregnancy[J]. Clin Obstet Gynecol, 2011, 54(4): 602-618. [65] Wolters V, Heimovaara J, Maggen C, et al.Management of pregnancy in women with cancer[J]. Int J Gynecol Cancer, 2021, 31(3): 314-322. [66] de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients[J]. Lancet Oncol, 2018, 19(3): 337-346. [67] Lishner M. Cancer in pregnancy[J]. Ann Oncol, 2003, 14 (Suppl 3): iii31-36. [68] Kiyota N, Tahara M, Mizusawa J, et al.Weekly cisplatin plus radiation for postoperative head and neck cancer (JCOG1008): a multicenter, noninferiority, phase Ⅱ/Ⅲ randomized controlled trial[J]. J Clin Oncol, 2022, 40(18): 1980-1990. [69] Zagouri F, Sergentanis TN, Chrysikos D, et al.Platinum derivatives during pregnancy in cervical cancer: a systematic review and meta-analysis[J]. Obstet Gynecol, 2013, 121(2 Pt 1): 337-343. [70] Sood AK, Shahin MS, Sorosky JI.Paclitaxel and platinum chemotherapy for ovarian carcinoma during pregnancy[J]. Gynecol Oncol, 2001, 83(3): 599-600. [71] Jänne PA, Rodriguez-Thompson D, Metcalf DR, et al.Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy[J]. Oncology, 2001, 61(3): 175-183. [72] Nuyttens JJ, Prado KL, Jenrette JM, et al.Fetal dose during radiotherapy: clinical implementation and review of the literature[J]. Cancer Radiother, 2002, 6(6): 352-357. [73] Owrangi AM, Roberts DA, Covington EL, et al.Revisiting fetal dose during radiation therapy: evaluating treatment techniques and a custom shield[J]. J Appl Clin Med Phys, 2016, 17(5): 34-46. [74] Albonici L, Giganti MG, Modesti A, et al.Multifaceted role of the placental growth factor (PlGF) in the antitumor immune response and cancer progression[J]. Int J Mol Sci, 2019, 20(12): 2970-3002. [75] He J, Shen N, Huang X.Thyroid carcinoma cells produce PLGF to enhance metastasis[J]. Tumour Biol, 2015, 36(11): 8601-8607. [76] Bu J, Bu X, Liu B, et al.Inhibition of metastasis of oral squamous cell carcinoma by anti-PLGF treatment[J]. Tumour Biol, 2015, 36(4): 2695-2701. [77] Radwan P, Tarnowska A, Piekarska K, et al.The impact of soluble HLA-G in IVF/ICSI embryo culture medium on implantation success[J]. Front Immunol, 2022, 13: 982518. [78] Ferreira LMR, Meissner TB, Tilburgs T, et al.HLA-G: at the interface of maternal-fetal tolerance[J]. Trends Immunol, 2017, 38(4): 272-286. [79] Liu L, Wang L, Zhao L, et al.The role of HLA-G in tumor escape: manipulating the phenotype and function of immune cells[J]. Front Oncol, 2020, 10: 597468. [80] Russell S, Angell T, Lechner M, et al.Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma[J]. Head Neck Oncol, 2013, 5(3): 24-40. [81] Tripathi S, Guleria I.Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus[J]. Biomed J, 2015, 38(1): 25-31. [82] Feldman R, Gatalica Z, Knezetic J, et al.Molecular profiling of head and neck squamous cell carcinoma[J]. Head Neck, 2016, 38(Suppl 1): E1625-E1638. [83] Hanna GJ, Woo SB, Li YY, et al.Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma[J]. Int J Oral Maxillofac Surg, 2018, 47(5): 568-577. [84] Fortner RT, Schock H, Kaaks R, et al.Early pregnancy sex steroids and maternal breast cancer: a nested case-control study[J]. Cancer Res, 2014, 74(23): 6958-6967. [85] Lukanova A, Surcel HM, Lundin E, et al.Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer[J]. Int J Cancer, 2012, 130(4): 910-920. [86] Lukits J, Remenár E, Rásó E, et al.Molecular identification, expression and prognostic role of estrogen- and progesterone receptors in head and neck cancer[J]. Int J Oncol, 2007, 30(1): 155-160. [87] Molteni A, Warpeha RL, Brizio-Molteni L, et al.Estradiol receptor-binding protein in head and neck neoplastic and normal tissue[J]. Arch Surg, 1981, 116(2): 207-210. [88] Sumida T, Ishikawa A, Mori Y.Stimulation of the estrogen axis induces epithelial-mesenchymal transition in human salivary cancer cells[J]. Cancer Genomics Proteomics, 2016, 13(4): 305-310. [89] Fei M, Zhang J, Zhou J, et al.Sex-related hormone receptor in laryngeal squamous cell carcinoma: correlation with androgen estrogen-ɑ and prolactin receptor expression and influence of prognosis[J]. Acta Otolaryngol, 2018, 138(1): 66-72. [90] Schwartz N, Chaudhri RA, Hadadi A, et al.17Beta-estradiol promotes aggressive laryngeal cancer through membrane-associated estrogen receptor-alpha 36[J]. Horm Cancer, 2014, 5(1): 22-32. |